Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Antineoplastic Biological Agent" in comments (approximate match)

Showing 71 - 80 of 183 results

First page
Previous page
Next page
Next page

LACUTAMAB

N8O7MY0VNS

Subunit 1 (448) Similarity Search Subunit 2 (448) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (448) Similarity Search Subunit 2 (448) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT03902184: Phase 2 Interventional Active, not recruiting Lymphoma, T-Cell

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03902184

Class:

PROTEIN

CIBISATAMAB

ZAM5J1ATF2

Subunit 1 (694) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search Subunit 5 (214) Similarity Search

Sequence Search

Subunit 1 (694) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search Subunit 5 (214) Similarity Search

Status:

Investigational

Source:

NCT03337698: Phase 1/Phase 2 Interventional Active, not recruiting Carcinoma, Non-Small-Cell Lung

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03337698

Class:

PROTEIN

ERTUMAXOMAB

L5L45YGP1O

Subunit 1 (16) Similarity Search Subunit 2 (16) Similarity Search Subunit 3 (16) Similarity Search Subunit 4 (15) Similarity Search

Sequence Search

Subunit 1 (16) Similarity Search Subunit 2 (16) Similarity Search Subunit 3 (16) Similarity Search Subunit 4 (15) Similarity Search

Status:

Investigational

Source:

NCT00522457: Phase 2 Interventional Terminated Metastatic Breast Cancer

(2008)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00522457

Class:

PROTEIN

SPARTALIZUMAB

QOG25L6Z8Z

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search

Sequence Search

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search

Status:

Investigational

Source:

NCT04544111: Phase 2 Interventional Active, not recruiting Thyroid Cancer

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04544111

Class:

PROTEIN

TIMIGUTUZUMAB

A5HYI6N66H

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

INN:timigutuzumab [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/A5HYI6N66H

Class:

PROTEIN

ADEBRELIMAB

1XBY50W1OX

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Sequence Search

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Status:

Investigational

Source:

NCT04316364: Phase 3 Interventional Recruiting Non-Small-Cell Lung Cancer

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04316364

Class:

PROTEIN

Renvistobart

81J55YFQ16

Subunit 1 (459) Similarity Search Subunit 2 (459) Similarity Search Subunit 3 (216) Similarity Search Subunit 4 (216) Similarity Search

Sequence Search

Subunit 1 (459) Similarity Search Subunit 2 (459) Similarity Search Subunit 3 (216) Similarity Search Subunit 4 (216) Similarity Search

Status:

Investigational

Source:

NCT04570839: Phase 1/Phase 2 Interventional Completed Endometrial Neoplasms

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04570839

Class:

PROTEIN

VANDORTUZUMAB

O5EGV7ISVU

Subunit 1 (454) Similarity Search Subunit 2 (454) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search

Sequence Search

Subunit 1 (454) Similarity Search Subunit 2 (454) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search

Status:

Investigational

Source:

NCT01283373: Phase 1 Interventional Completed Prostate Cancer

(2011)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01283373

Class:

PROTEIN

SACITUZUMAB

73H2I6QS54

Subunit 1 (451) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (451) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

INN:sacituzumab [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/73H2I6QS54

Class:

PROTEIN

VANUCIZUMAB

B800Z06O8K

Subunit 1 (463) Similarity Search Subunit 2 (453) Similarity Search Subunit 3 (213) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (463) Similarity Search Subunit 2 (453) Similarity Search Subunit 3 (213) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT02665416: Phase 1 Interventional Completed Advanced/Metastatic Solid Tumors

(2016)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02665416

Class:

PROTEIN

Protein

Protein

Protein

Protein

Protein

Protein

Protein

Protein

Protein

Protein

Showing 71 - 80 of 183 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1